chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient stated she woke up in the middle of the night in the early morning after she got the shot. Injection arm was painful and warm and red about the middle to inner upper arm. She states she went to see doctor on 10/20/2018 and was diagnosed with cellulitis. Was prescribed doxycycline. Called patient for an update on 10/21/2018 and she said arm was getting better. I asked if she was taking ibuprofen or acetaminophen, she said she wasn't and I advised that she take that.
Red, slightly swollen circle around injection site about 1.5 to 2" in diameter.; Red, slightly swollen circle around injection site about 1.5 to 2" in diameter.; Painful when touched and warm to touch the injection site.; Painful when touched and warm to touch the injection site.; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: unknown) via an unspecified route of administration in the left arm on 19Apr2021 (at the age of 22-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient received other medications within 2 weeks of vaccination included bupropion (WELLBUTRIN) for an unspecified indication. The past drug history included amoxicillin for unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested positive for COVID-19. On 20Apr2021, the patient experienced red, slightly swollen circle around injection site about 1.5 to 2 in diameter and she had painful when touched and warm to touch the injection site. The clinical outcome of red, slightly swollen circle around injection site about 1.5 to 2 in diameter,  painful when touched and warm to touch the injection site were not resolved at the time of this report.  Information about lot/batch number cannot be obtained. No further information is expected.
Received vaccine on 12/21/2020.  Developed constipation that cleared on 12/26/2020 with use of colace.  Had episode of diarrhea on 12/28/2020.  Abdominal pain began at 2330 on 12/29/2020 and worsened through the night.  Went to ER at 0500 hours on 12/30/2020 where I was diagnosed with appendicitis and underwent appendectomy on the same day by Dr.  I have no idea if this is related to the vaccine or simply a coincidence.  In error of caution, I am reporting this.  Thank you.
PATIENT INDICATED SHE WAS HESTITANT TO GET THIS VACCINE BUT WAS ONLY DOING IT BECAUSE HER HUSBAND'S PLACE OF WORK IS REQUIRING IT AND SHE HAS UPCOMING TRAVEL PLANS.   IMMEDIATELY AFTER INSERTING THE NEEDLE INTO HER ARM, SHE SAID "OUCH" AND THEN MADE FACIAL EXPRESSIONS THAT LOOKED LIKE SHE WAS UNCOMFORTABLE.  AFTER WARD SHE SAID "THAT ONE HIT ME HARD" AND HER HUSBAND AND I WERE ASKING IF SHE WAS OKAY AS SHE LOOKED TO BE GETTING FAINT.  WE KEPT TALKING TO ASKING HOW SHE WAS DOING AND EVENTUALLY HER HUSBAND BEGAN MASSAGING THE BACK OF HER NECK AND HE SAID THAT'S WHAT HE DOES TO BRING HER 'OUT OF THESE EPISODES'.   AFTER SOME TIME, SHE BEGAN TO REGAIN CONSCIOUSNESS  AND FOCUSING HER EYES.   I OFFERED HER WATER AND ASKED IF SHE'D EATEN.  DUE TO HER DIET AND FASTING THAT  SHE'S DOING, SHE HADN'T EATEN IN ALMOST 24 HOURS.  SHE DECLINED A PROTEIN BAR.  SHE ALSO DECLINED ANY EMT OR AMBULANCE SERVICE.     THEY REMAINED IN THE STORE WAITING FOR HER TO REGAIN HER STRENGTH, BECAUSE SHE WOULD BECOME FAINT AGAIN EACH TIME SHE TRIED TO GET UP.  EVENTUALLY HER HUSBAND LEFT WITH HER IN A MOTORIZED CART AND WAS COMFORTABLE TAKING HER HOME.  HE SAID HE WORKS HER THROUGH THESE KINDS OF EPISODES WHEN THEY OCCUR DUE.  THEY TOLD ME THEY CAN BE TRIGGERED IF SHE BECOMES LIGHT HEADED OR IF SHE'S EXPOSED TO FLASHING LIGHTS.  THEY ALSO TOLD ME THAT SHE HAS BEEN EXPERIENCING THESE EPISODES SINCE BEING IN A CAR WRECK A FEW MONTHS AGO WHERE SHE SUFFERED SEVERE WHIPLASH
Chills; Fatigue; Redness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), FATIGUE (Fatigue) and VACCINATION SITE ERYTHEMA (Redness at the injection site) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history provided). Concomitant products included LORATADINE and FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF) for Allergy, ESTRADIOL.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced CHILLS (Chills), FATIGUE (Fatigue) and VACCINATION SITE ERYTHEMA (Redness at the injection site). On 15-Jan-2021, CHILLS (Chills) and FATIGUE (Fatigue) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (Redness at the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications included Paracetamol.
10/16/09 @ 4:00 PM patient given flu vaccine.  Within the minute patient mention lump & hotness.  Immediately called Dr. for observation on left arm.
Pt recv vax on 3/9/99; on same day pt exp flu-like sx w/ body aches, fever, chills
Patient called reporting that her left upper arm, where she received the Pneumonia vaccine, is very sore and has a knot. Pt also, reports that she had a low grade fever all on last evening after getting the vaccination. Pt reports that it is better today.
stated feeling dizzy on sunday morning while asleep and throughout the day sunday and monday when asleep or moving the head suddenly.
advised to wait 30 min post shot for monitoring d/t latex allergy. completed without s/s. returned approx 20 min c/o itching to arm at injection site, stated, throat had been internally itchy for about 10 min after leaving vaccination area but that passed on its own. advised to use cold compress on arm and monitor self. let vaccination center without questions, concerns.
At 1540 RN came to Lead office and informed Co-Lead  that she had erroneously vaccinated client  two days before his second dose of Moderna was due. Co-Lead went to the vaccination room, verified client's identity, and confirmed Client's first dose of Moderna was given on 5/12/2021, and therefore, his second dose was due 6/9/2021.  On the back of the vaccination card, the reminder erroneously listed today, June 7, 2021, as the return date and this is why Ancillary and Vaccinator proceeded with the vaccination.  Moderna, lot# 027C21A vaccine was given to client at 1536. Using vaccinator to translate into Spanish, the RN informed client that a VAERS and VERP report would be filed, and client verbalized understanding. RN then educated the vaccination team  that client's info should always be screened for the appropriateness of receiving a second dose by verifying when the first dose was received, and not to rely on what the vaccination card says.  Co-lead also educated check-in RN, Co-Lead Ancillaries, and Ancillary working with vaccinator regarding the importance of verifying each client's first vaccination date before sending them upstairs for their second dose.  Co-lead verified that she would reiterate the importance of date verifications with all ancillary staff.  Client was informed VAERS and VERP would be submitted.
Information has been received from a physician concerning a patient (age and gender not reported) with no pertinent medical history or drug reactions/allergies who on an unspecified date was vaccinated with a dose of GARDASIL (lot number unknown). On an unspecified date the patient developed migratory arthralgia. At the time of reporting it is unknown if the patient had recovered. The physician considered migratory arthralgia to be an other medical event (OME). Additional information is not expected. This is one of two reports.
Worst Headache of life with ED visit, non diagnostic CNS venogram with normal platelets on 4/14/2021. Phone visit today with persistent headache. Advised to return to the ED today for evaluation.
This spontaneous report was received from a nurse refers to a 6 months old patient of unknown gender. The patient's relevant medical history, concurrent conditions, concomitant medications, drug reactions or allergies were not reported. On 04-OCT-2017, the patient was vaccinated with improperly stored ROTATEQ (dosing details were not reported) (lot # N009948, expiry date: 12-OCT-2018) orally for prophylaxis. No adverse effects were reported. Temperature excursion was from 0 degree Celsius (C) to 1 degree C (0.8 degree C) for 52 minutes. The previous temperature excursion was reported as from 9 degree C to 25 degree C (10.9 degree C) for 3 hours 17 minutes. The call was because of a data logger. No product quality complaint involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1709USA007014: US-009507513-1709USA007011: US-009507513-1709USA007012: US-009507513-1709USA007013: US-009507513-1709USA000054.
The symptoms started has red dots on my feet after the second dose and started to spread all over my body.  My testosterone and thyroid have been negatively affected. My blood pressure has been affected as well.
After arriving home at 5:15 I became very fatigue and needing to lay down asap. I was awoken around 3:30am on the 6th with the shakes, chills, severe head and back ache and body aches. Urgent  and frequent urination. This continued from that point all through Sunday evening on the 7th. Symptoms started to go away later in the evening except for headaches which are still present at this time.
After 1 day from receiving the vaccine the patient observed her arm becoming red, swollen and painful. She went to seek treatment from her Dr. office and received prednisone and doxycycline.
patient received an expired VAQTA; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. There was no information about patient's concomitant medications, concurrent conditions or pertinent medical history.  On 15-JUN-2021, the patient was vaccinated with a dose of hepatitis a vaccine, inactivated (VAQTA), 1 ml, lot # S025258 with expiration date 05-NOV-2020 (route and anatomical location were not reported) for prophylaxis. combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: S025258; expirationdate: 05-NOV-2020; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not suggest a causal association with the device or device constituent
approx 3 hrs p/vax pt noted tearing eyes, facial swelling, sl SOB, sore throat, coughing; pt MD prescribed DPH which relieved SOB; pt sx lasted aprpox 16-18 hrs;
Patient received a dose of vaccine that may be less than completely effective due to storage conditions.  No adverse reaction reported
Last dose was Pfizer but nurse gave Moderna for patient's 2nd dose. After 1 hour patient began to feel extremely tired, headache, dizziness, feels like she can't breath deep enough. Still feels these symptoms at 3:15 pm 4/15/2021 same day at time of this report.
Health event 1: Started COVID symptoms on 02/07/2023.  Tested positive 02/10/2023 and 02/17/2023.  Tested negative on 02/19/2023.   Health event 2:  Heavy sinus drainage started 03/20/2023. Took Claritin and sudafed but was ineffective.  Visited doctor on 04/10/2023.  Diagnosed with Rhinosinusitus.  Treating with Zyrtec, Flonase, and nasal rinse.
Patient reaction approximately 2 minutes after dose administered. Faintness, dizziness. We had her sit in a chair initially take her mask off.  Drank some orange juice. She got worse over the following few minutes. Lost feeling, ability to move her hands/fingers. We had her lay flat on floor. She reported the loss of movement/feeling in her feet as well.  After 5 minutes of laying on floor, she slowly got normal function back in her hands/feet.  Was able to sit back up in chair after 10 minutes of laying on floor.  Recovered progressively over the next 15 minutes.  She contacted friend to pick her up instead of driving herself home after roughly 30 minutes.
SWELLING OF LIPS, TINGLING OF BODY. SHORTNESS OF BREATH. LASTED FOR 5 DAYS. PATIENT TAKING BENADRYL.
Patient received Moderna COVID vaccine on 2/1/2021 and 2/22/2021.  Pt. presented to Medical center within Health system with weakness and arm and leg swelling on 3/4/2021.  Admitted for observation, tested negative for COVID and discharged on 3/5.  Pt. presented to Medical Center, also within Health system on 5/2/2021 complaining of SOB.  Stated that she has had non-productive cough for months, but felt it had worsened lately.  Pt. found to be COVID positive with bilateral infiltrates.   Pt. required 6L O2.  Pt. was DNRCCA.  Pt. not intubated but expired from cardiac arrest/COVID on 5/16/2021.
"SM received first dose of Pfizer vaccine almost immediately SM felt flush, anxiety, jittery, nausea.  SM moved to alcove for additional monitoring. VS  1026 HR 78, BP, 145, 99% 1035 HR 72, 150/97 1046 HR 72 150/89 1056 HR 62, 146/88 1106 HR 60, 143/102 SM manager notified that SM would be transported to ED as symptoms did not resolve and would be going home. returned to unit.  SM accompanied to ED for additional treatment /monitoring."
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 62-year-old male patient received BNT162b2 (BNT162B2), on 26Dec2020 at 10:30 as dose 1, single (Lot number: EH9899), in left arm, on 16Jan2021 at 11:00 as dose 2, single (Lot number: EK9231), in left arm and on 16Oct2021 at 09:00 as dose 3 (booster), single (Lot number: 32030BD) at the age of 61 years, in left arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 14May2022 at 11:00 as dose 4 (booster), single (Lot number: 002M21A), in left arm for covid-19 immunisation. The patient's relevant medical history included: "seasonal allergies" (unspecified if ongoing), notes: seasonal allergies. Concomitant medication(s) included: ASPIRIN [ACETYLSALICYLIC ACID] oral, start date: 19Nov2017. Past drug history included: Finasteride, reaction(s): "Known allergies: Finasteride", notes: Known allergies: Finasteride. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of vaccination failure, covid-19 included COVID-19 Treatment included PAXLOVID from 26Jul2022 to 01Aug2022.; Sender's Comments: Based on available information, a possible contributory role of Comirnaty vaccine cannot be excluded for the reported events.
She "had a fever but just had it overnight; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non-HCP) from medical information team. The reporter is the patient.  A 70-year-old female patient received bnt162b2 (BNT162B2), administration date 08Oct2021 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunization. Relevant medical history included: "She just have "different allergies"" (unspecified if ongoing), notes: She just have "different allergies". The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1, Manufacturer Unknown), administration date: 18Jan2021, for COVID-19 Immunization, reaction(s): "Had severe reaction (itching arm)"; Bnt162b2 (Dose: 2, Manufacturer Unknown), administration date: 08Feb2021, for COVID-19 Immunization, reaction(s): "Had severe reaction (itching arm)". The following information was reported: PYREXIA (non-serious) with onset 2021, outcome "recovered" (2021), described as "She "had a fever but just had it overnight". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: The patient stated that she had her first shot on 18Jan2021 and had her second shot on 08Feb2021, and she received her booster shot by 08Oct2021. The patient mentioned that she will be having her second booster dose this 08Mar, as suggested by her healthcare provider. Also stated that, she heard that mixing up vaccines suggest a higher immunity against COVID19. The patient also mentioned that she experienced different side effects after getting the shot. During her first dose, she had severe reaction (itching arm) that lasted 3 weeks. The "second dose was much easier." The patient stated that on her third dose, she "had a fever but just had it overnight." She had antibody test made by her doctor and she got "500". After getting the booster dose, her antibody went "2000 way up." The patient mentioned that her doctor was under clinical trial for COVID19 vaccine and was the one recommending her to get her 2nd booster dose.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This 26 year old female had chicken pox as a child. Her son received varicella vax on 01/05/2000. On 01/21, the mother developed "full blown chicken pox" with greater than 50 lesions and a fever of 102.0 F. She sought medical attention and was treated with acyclovir for one week. A PCR analysis was obtained. It was also noted that the pt was 22 weeks pregnant. Her son also experienced reaction post vax.
Vertigo; red whelt on her injection arm; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo) and VACCINATION SITE URTICARIA (red whelt on her injection arm) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 011L20A) for COVID-19 vaccination.     Concurrent medical conditions included Immunosuppression.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Feb-2021, the patient experienced VERTIGO (Vertigo). On an unknown date, the patient experienced VACCINATION SITE URTICARIA (red whelt on her injection arm). At the time of the report, VERTIGO (Vertigo) and VACCINATION SITE URTICARIA (red whelt on her injection arm) outcome was unknown.            No treatment information was provided.
Patient with extreme fussiness, inconsolable crying, jerky movements in arms, eyes going back and forth episodes lasted 15-20 seconds and had 7-8 episodes. Vomiting.
I received shot about 10:30 AM. About an hour later I noticed soreness and itching. About 12:00 PM arm was paiful, hot and swollen. Also redness expanded to half of upper arm. By the night, arm was swollen 2 times size and hot and red whole upper arm and pain. By 4:00 PM arm was very swollen and painful. By 6:30 very red and large swelling (no temp). Took 2 ADVIL for pain.
On 3/7/2022 at 1501 the patient was given a dose of the Pfizer vaccine which was diluted 6 hours and 30 minutes prior to the patient receiving. The vial of vaccine was mixed at 0830 and the vaccine was given at 1501. The vaccine box insert states that the vaccine should be discarded after six hours.
fatigue was about 6 hours post vaccination, 12 hours after vaccination + fatigue, Headache, muscle and joint pain/aches and chills, ibuprofen taken and resolved HA.  24-30 hours post vaccination + severe body aches (bone pain) and chills.  All symptoms resolved at 30 hours post vaccination
Child developed vesicular rash at site of injection. rash spread rapidly in dermatomal distribution and consistent with shingles. Treated with oral acyclovir and improved.
Client passed out, dizzy after coming to. Elevated feet, had client lay down for a few minutes prior to standing/sitting up.
The patient reported chest pain during/after gym class.   The school nurse noted elevated heart rate.  He was sent home from school to rest.  The patient?s pediatrician was contacted and parents were informed to administer oral NSAIDs.  (Ie ?Motrin?) .  However what we had was Aleve (naproxen 220mg).  This alleviated symptoms for approximately 10 hours, it which point symptoms would return and another tablet was given (Repeat approximately 4-5 times).
Patient began to go pale and sweat about 3 minutes after receiving his first Pfizer shot. The patient then passed out and had some convulsions. This last for about 5 seconds and happened twice about 30 seconds to a minute apart. Afterwards the patient stated that his tongue felt "funny" and looked a little swollen. The patient was observed and 911 was called. He was evaluated by EMT staff and seemed to be back to normal about 30 minutes later.
Sore arm for 72 hours after shot.  8 days after shot a red swollen spot where shot was given with a white ring and bruise trailing down arm for 48 hours now
Information has been received from a medical assistant concerning a 7-year-old female patient who on 06-JUL-1999 was vaccinated with a dose of varicella virus vaccine live. On approximately 28-DEC-2005, the patient developed chickenpox. Unspecified medical attention was sought. There was no product quality complaint involved. No further information was available. Additional information has been requested.
Daughter at 3 months, experienced swelling and pain in her legs at the sites where injections were administered.
14-16 hours after the shot with severe chills, jackets on, and heated blanket. the shakes, headache, vomiting, and it didn't hit until the 14-15th hour. I saw a doctor and I wanted to make sure if it was part of the COVID-19 shot. I was in bed for the first shot for 2 weeks. I was really sick and nauseous. COVID-19 positive in April 2020, Coma for 5 months from 4/26/2020 - 08/2020. Coded 3 times during coma and was in hospice 3 times.
URINARY TRACT INFECTION; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine  (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on MAY-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAY-2021, the subject experienced urinary tract infection. The action taken with covid-19 vaccine  was not applicable. The outcome of urinary tract infection was not reported. This report was non-serious. This case, from the same reporter is linked to 20210603257.